Date	1 Nov 2010, 6 weeks
Price	EUR 625.00 / GBP 499.00 Members of our Training Partnership scheme pay EUR 312.00 / GBP 249.00
Get	Course brochure [366kb]
Book	Book now online or learn about other ways of booking

Length	6 Modules - immediate download available (when paying online)
Price	EUR 499.00 / GBP 399.00 (+VAT @ 17.50)% Members of our Training Partnership scheme pay EUR 312.00 / GBP 249.00 (+VAT @ 17.50%)
Book	Book now online or learn about other ways of booking

Course overview

Understanding the dynamics and drivers of the industry you work in is key to understanding how and why key decisions are made within your organisation. In turn, this enables you to appreciate your potential impact on the overall success of the organisation. With this in mind, Falconbury have developed this concise distance learning course which delivers a complete insider’s guide to the pharmaceutical industry; it’s history and background, the process of discovery, clinical trials, taking the drug to market; the challenges and opportunities facing the industry now and in the future. If you are new to the industry, or are in a support role or otherwise would like to broaden your understanding of the environment in which you work, then this programme is essential for your development.

Who should take this course?

Anyone working within the industry who is new to it or who would like to broaden their understanding of the pharmaceutical industry and who works in any of the following functions:

• R & D: all areas of drug discovery and development, including clinical, and regulatory affairs
• Production and quality assurance
• Marketing and sales
• Business development and licensing
• Finance
• Legal
• Human resources
• Administrative support

This course will:

• PROVIDE a review of the dynamics and drivers of the industry
• OUTLINE the drug development process, including pre-clinical activities
• DEFINE the key challenges faced in registering a drug
• FOCUS on the function and importance of alliances and deals
• ENABLE you to get-to-grips with the journey through each clinical trial phase
• EXPLAIN the particular marketing and selling strategies, tactics and techniques employed in the pharmaceutical industry
• EXAMINE the current and future trends and their implications across the sector

Course modules

MODULE 1 – INTRODUCTION TO THE PRESCRIPTION PHARMA INDUSTRY

• The structure of the pharmaceutical industry; international importance
• A brief history
• Medicines classification
• How the nature of disease and drug treatment relates to industry therapeutic areas
• Mission statements and therapeutic goals
• What is distinctive about the pharmaceutical industry?
• The importance of intellectual property rights

MODULE 2 – DRUG DISCOVERY AND PRE-CLINICAL ACTIVITIES

• The target product profile
• Key milestones in the development process
• Drug synthesis and selection; safety; animal pharmacology; ADMET
• Biotechnology/start-ups – differences between biotech and pharma companies
• Contract research organisations
• Enabling technologies

MODULE 3 – FROM CLINICAL TRIALS TO REGISTRATION

• GCP
• Data management and statistics
• Clinical trials by phase
• Attrition rates
• Pharmaceutical development
• Manufacturing (including GMP)
• Quality control/assurance
• Drug registration
• Orphan drugs

MODULE 4 – BUSINESS DEVELOPMENT

• The function of business development
• The importance of strategic alliances
• Mergers and acquisitions

MODULE 5 – HOW DRUGS ARE MARKETED AND SOLD

• Pharmaceutical market research
• Marketing strategies
• Promotional activities – the sales force and advertising
• Pricing
• Distribution
• Parallel trade
• Who’s who in the marketing department

MODULE 6 – CURRENT AND FUTURE TRENDS

• Emerging geographical markets
• US vs Europe
• Product life-cycle management (including Phase IV development)
• Strategy for new therapeutic markets
• Barriers to future entry
• Diversification away from pharmaceuticals

Course contributor

JOHN ANSELL
Since 1989 John Ansell has been a pharmaceutical industry consultant. He concentrates on international projects with a commercial and strategic emphasis, reflecting his previous industry experience in marketing and business development. He has worked with many major pharmaceutical companies but advises companies of all sizes including start-ups, as well as those providing services to the industry and those investing in it: some 110 clients in all.

A Biochemistry graduate with a Masters degree in Business Studies, John started his 20-year career in the pharmaceutical industry in Holland with Organon. He subsequently worked for Schering AG and Fisons in the UK, and again in Holland, with Solvay. Lastly, from 1985 to 1989 he worked in international marketing for Glaxo Holdings.

He is the author of over 40 articles and reports on pharmaceutical issues. His most recent article is Product Life Spans: Trends in the Quality and Staying Power of New Products(Spectrum, Decision Resources, June 2008).

He has advised numerous investment banks including six of the top seven; he is placed in the top 5% Leader category of the Gerson Lehrman Group’s consultants, based on quality of interaction with its financial and consultancy clients. He is also Honorary Consultant to the University of Manchester School of Pharmacy and Pharmaceutical Sciences.

John is a frequent speaker at industry conferences on various aspects of deals, marketing and R & D strategy. He has presented on US and European biotech deals, on deals involving genomics, generics and OTC, as well as widely on mergers and alliances. He was founding Director in 2005 of Falconbury/Informa’s Pharma Executive Mini-MBA course. He has also acted as chairman at well over 30 pharmaceutical conferences, on a wide range of topics including biotechnology, R & D, business development and licensing, technology transfer, due diligence, marketing, promotion, pricing and corporate governance.

John was a long-standing member of the Editorial Advisory Board of the US journal Pharmaceutical Executive (1990-2002), served on the Editorial Board of the Journal of Biotechnology in Healthcare (1994-98), and has been Chairman of the Advisory Board of Decision Resources since its inception in 2005.

Past delegates’ comments

Some of the comments received by participants on this course:

You might also be interested in...

Delegates who attended this course also went on the following courses:

Client portfolio

Our client portfolio for this course includes the following companies:

AMT Bv	Dafra Pharma International NV	Mylan
Actavis Turkey	EFTA SURVEILLANCE AUTHORITY	Novartis Vaccines & Diagnostics GmbH
Almac Clinical Services	Galderma International	Otsuka Pharmaceutical Europe Ltd
Amdipharm plc	Genesis Pharma SA	Pharming Group
Archimica GmBH	GlaxoSmithKline Biologicals SA	Sanofi Aventis Group
Astra Zeneca	GlaxoSmithKline plc	Sanofi-Aventis
Astra Zeneca UK Ltd	Global Embarks Ltd	Solvay Pharmaceuticals
Axellia Pharmaceuticals	ICON Clinical Research (UK) Ltd	UCB SA/NV
Basilea Pharmaceutica AG	Intercell AG	Warner Chilcott
Bosnalijek JSC	Johnson & Johnson NCB	Williams Medical Supplies
Centrala Farmaceutyczna CEFARM SA	Merckserono SA
Chiesi Farmaceutici SpA	Moorfields Pharmaceuticals

More information

The following documents are available for this course:

• Sample module [327kb]

Falconbury’s distance learning programmes have been certified by the Academy of Distance Learning (ADLiB).. ADLiB supplies an unbiased authentication of, and quality assurance for, distance learning programme providers.

Upon course completion, distance learning participants are invited to undertake a final external assessment in the form of an online multiple-choice paper.

Participants are required to achieve a pass rate of 80% and above to ensure that a high level of competence has been achieved within the subject area and to receive the advanced ‘Certificate of Excellence’. The final external assessment can be taken up to three times, thereafter the ‘General Certificate of Course Completion’ will be issued.

NB: The final external assessment is an optional appraisal and those participants not wishing to undertake it will automatically receive the ‘General Certificate of Completion’ for their personal development/training profile.

Find out more about ADLIB here.

Academy of Distance Learning in Business

ADLiB

Falconbury’s distance learning programmes have been certified by the Academy of Distance Learning (ADLiB). ADLiB supplies an unbiased authentication of, and quality assurance for, distance learning programme providers.

Upon course completion, distance learning participants are invited to undertake a final external assessment in the form of an online multiple-choice paper.

Participants are required to achieve a pass rate of 80% and above to ensure that a high level of competence has been achieved within the subject area and to receive the advanced ‘Certificate of Excellence’. The final external assessment can be taken up to three times, thereafter the ‘General Certificate of Course Completion’ will be issued.

NB: The final external assessment is an optional appraisal and those participants not wishing to undertake it will automatically receive the ‘General Certificate of Completion’ for their personal development/training profile.

Find out more about ADLIB here.

International Association of Distance Learning

The International Association for Distance Learning (IADL) promotes excellence in open, distance, and online learning worldwide, and provides a benchmark through which global consumers can gauge the quality of courses offered by their members.

 

The IADL is an independent, non-profit organisation with its principal administrative offices in London in the United Kingdom. Find out more.

 

Falconbury are an Approved Member of the International Association for Distance Learning. Please see our IADL membership certificate

Please follow the steps below to get your download distance-learning programme.

CHOOSE YOUR PROGRAMME: Select the distance-learning course you wish to download and click the download tab and click Book now online.

GO TO MY BASKET: Now go to your basket in the grey band at the top of the screen and click View basket.

5 STEP BOOKING PROCESS

Step 1: Choose what currency you would like to pay in and how you would like to pay (NB: Don’t forget to click your acceptance of the T&Cs).

If you have an Account with Falconbury already, then Log in, then click Proceed.

If not

CREATE AN ACCOUNT: Click on Log in, then click the blue Register here button and then follow the instructions. Once you have filled in your details, click the Register button.

Step 2: Fill in any contact details that are missing where requested and click Next.

Step 3: Check the ‘Course Summary’ and make sure you have the right programme and price. Also, fill in your PO/reference number if you have one, then click Next.

Step 4: Fill in the participant(s) details, the click next.

Step 5: Ensure you are happy and click make booking.

Upon booking

PAYMENT & DOWNLOADING…

• Payment can be made either by credit card or invoice

• If payment is made via credit card when the booking is placed, the files will be available to download immediately from your account.

• Click on My Account in the grey band at the top of the page. Then click on My Bookings where you will see your booking listsed.

• Click on full details on the right hand side of your booking listing.

• Your download modules will now be listed. The password for each module will be listed on the right-hand side of each listing.

NB: If you are paying via invoice then the files will be available to download from your account as soon as cleared payment has been received.

• Please be aware all download files are encrypted, your password to access the files will also be displayed in your account when your download is available.